Prostate Cancer Clinical Trial

Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study

Summary

This is a pilot evaluation of a patient-centered intervention that enables providers to support men on active surveillance to maximize adherence. Conducted in urology practices, this pilot will measure key patient-reported, provider-reported, and implementation outcomes. Successful completion of this work will inform a subsequent multi-center effectiveness-implementation hybrid design trial and ultimately will improve low-risk cancer management by effectively engaging Primary Care Physicians (PCPs) in care delivery.

View Eligibility Criteria

Eligibility Criteria

Patient Inclusion Criteria:

55 years old or older
Men diagnosed with low-risk prostate cancer currently on active surveillance
Men who identify having a primary care provider
Access and ability to use the Internet

Patient Exclusion Criteria:

Men who are unable to read and/or speak English
Men with impaired decision-making capacity (such as with a diagnosis of dementia or memory loss)

PCP Inclusion Criteria:

Identified by patient on baseline survey as their PCP

Urologist and Clinic Staff Inclusion Criteria:

Clinicians or staff at a participating urology clinic, including but not limited to MDs, APPs, and nurses

Study is for people with:

Prostate Cancer

Estimated Enrollment:

40

Study ID:

NCT05764005

Recruitment Status:

Recruiting

Sponsor:

University of Michigan Rogel Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Michigan Rogel Cancer Center
Ann Arbor Michigan, 48109, United States More Info
Cancer AnswerLine
Contact
800-865-1125
[email protected]
Archana Radhakrishnan
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

40

Study ID:

NCT05764005

Recruitment Status:

Recruiting

Sponsor:


University of Michigan Rogel Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.